I04-Macromolecular Crystallography
|
Niall A.
Anderson
,
Bernard
Barlaam
,
Argyrides
Argyrou
,
Peter C.
Astles
,
Hanna
Bruss
,
Elaine B.
Cadogan
,
Luca
Carlino
,
Luz
Alonso-Crisostomo
,
Gavin W.
Collie
,
Alex J.
Edwards
,
Anastasiia
Gryniukova
,
James
Hall
,
Kunzah
Jamal
,
Joshua
Kent
,
Linda
Kitching
,
Christopher
Kourra
,
Carolyn
Lam
,
Alexander G.
Milbradt
,
Jenni
Nikkilä
,
Sarah
Northall
,
Mark J.
O’connor
,
Jeroen
Overman
,
Claudio
Pathe
,
Wendy
Savory
,
Daniel
Slade
,
Jonathan A.
Spencer
,
Darren
Stead
,
Christopher J.
Stubbs
,
Benjamin C.
Whitehurst
,
Sabrina
Winfield
Diamond Proposal Number(s):
[20015]
Abstract: 2′-Deoxynucleoside 5′-monophosphate N-glycosidase (DNPH1) has emerged as an attractive target for cancer therapeutics exploiting DNA damage response pathways, yet chemical degraders for interrogating DNPH1 biology are lacking. We report the accelerated discovery of potent DNPH1 PROTACs using a direct-to-biology synthesis and screening platform. We employed miniaturized, array-based chemistry to generate a broad library of quinazoline-based PROTACs capable of recruiting a variety of different E3 ligases. Screening crude reaction mixtures in a cellular degradation assay enabled rapid identification of multiple nanomolar DNPH1 PROTACs, exemplified by compound 59, which achieved near-complete DNPH1 degradation and demonstrated strong functional activity in BRCA1 mutant cell lines. Mechanistic studies confirmed selective, proteasome- and VHL-dependent protein knockdown and recapitulation of phenotypic outcomes observed with DNPH1 genetic loss, including sensitization to hmdU treatment. Our findings highlight the power of D2B methodology to streamline PROTAC development and establish quinazoline-based degraders as robust chemical tools to advance DNPH1-targeted cancer research.
|
Nov 2025
|
|
labSAXS-Offline SAXS and Sample Environment Development
|
Diamond Proposal Number(s):
[40538]
Open Access
Abstract: A facile, stepwise synthetic route has been developed to access symmetric double [5]helicene diimides and their planar nanographene diimide counterparts via a C-shaped asymmetric [5]helicene. The synthetic strategy employs benzannulation and Scholl reaction methodologies to achieve progressive π-extension, yielding a new class of n-type rylene diimides with reversible redox characteristics. These helical and planar diimides exhibit variable crosswise π-conjugation and structural tunability, resulting in emission wavelengths that can be tailored alongside enhanced photoluminescence quantum yields—from 12% for the S-shaped diimide, to 57% for the C-shaped intermediate, and up to 63% for the fully planar nanographene diimide. Such properties make them promising candidates for quantum photonics, particularly as single-photon emitters. Photophysical properties, including time-resolved photoluminescence and transient absorption spectroscopy, reveal correlations between molecular structure, exciton dynamics, and emission behaviour. Notably, these helical rylene diimides demonstrate high photoluminescence efficiency in the solid state, reaching up to 32%, positioning them as strong contenders for next-generation optoelectronic devices.
|
Nov 2025
|
|
I04-Macromolecular Crystallography
|
Diamond Proposal Number(s):
[31850]
Abstract: The enantioselective manipulation of abundant flat (hetero)aromatic building blocks through either dearomatization, to establish new stereocenters, or cross-coupling, to construct a stereogenic axis, is an attractive means to generate three-dimensional molecular architectures. By merging the selectivity of engineered biocatalysts with the versatility of chemical synthesis, we establish a new platform for the metal-free enantioselective manipulation of sulfur-containing heteroaromatics, allowing either point or axial chirality to be set. The key to this approach is our ability to leverage the prochirality of sulfur heteroarenes; biocatalytic oxidation of benzothiophenes “switches on” reactivity and establishes a sulfur stereocenter that directs the stereochemical course of subsequent cross-couplings with non-prefunctionalized partners. Exploiting a previously unexplored mechanism, either point-to-point or point-to-axial chirality transfer from sulfur selectively delivers two different sets of chiral molecules. Enzyme evolution is used to convert a wild-type oxygenase into an efficient and selective engineered S-oxygenase capable of furnishing enantiopure benzothiophene S-oxides─little-known sulfoxides whose configurational stability we map out. Our integrated chemoenzymatic approach provides a blueprint for unlocking the potential of sulfur chirality, lying dormant in important heterocycles, to direct transformations that deliver diverse enantioenriched products.
|
Nov 2025
|
|
I15-1-X-ray Pair Distribution Function (XPDF)
|
Diamond Proposal Number(s):
[36120]
Open Access
Abstract: Chiral organic glasses combine unique optical properties with the processing advantages of amorphous solids. Here, melt-quenching as a strategy for preparing optically active glasses from enantiopure BINAP (2,2′-bis(diphenylphosphino)-1,1′-binaphthyl), a pivotal ligand in asymmetric catalysis and for luminescent metal complexes is demonstrated. Thermal characterization reveals that only R-BINAP and S-BINAP, not rac-BINAP, form molecular glasses with glass transition temperatures near 100 °C. Pair distribution function analysis and circular dichroism confirm the retention of local structure and homochirality despite the loss of long-range order. Remarkably, the glassy state has a beneficial influence on the molecular optoelectronic properties relative to the crystalline state, resulting in an increase of the radiative rate constant by ≈30%, attributed to more favourable Franck-Condon factors. In addition, a highly unusual simultaneous enhancement of circularly polarized luminescence (CPL) by nearly an order of magnitude is observed, achieving dissymmetry factors |glum| approaching 10−2 that are competitive with the top-performing purely organic molecular chiral emitters reported to date. These findings establish melt-quenched chiral molecular glasses as promising platforms for advanced optoelectronic and photonic materials, combining exceptional chiroptical properties, strong luminescence, and processability without the constraints of crystallinity.
|
Nov 2025
|
|
I03-Macromolecular Crystallography
I04-Macromolecular Crystallography
I24-Microfocus Macromolecular Crystallography
|
Abstract: Biocatalytic hydrogen atom transfer (HAT) holds the potential to help address some long-standing challenges in organic synthesis. Although several families of enzymes rely on cysteine to perform HAT, these enzymes are rather impractical for synthetic purposes. To circumvent possible side reactions associated with cysteinyl radicals, we report herein artificial hydrogen atom transferases (AHATases) with an abiological thiophenol cofactor, capitalizing on biotin–streptavidin technology. Chemogenetic optimization afforded an AHATase with good reactivity and high enantioselectivity (er up to 93:7) for the photoinduced radical hydroamination of alkenes. Crystal structures suggest that aromatic-sulfur interactions are key contributing factors to cofactor anchoring and enantioinduction. Mechanistic studies support H atom abstraction and donation processes, both of which are catalyzed by the AHATase. Our work highlights the synthetic potential of thiol-based biocatalytic HAT and expands the repertoire of HAT biocatalysis.
|
Nov 2025
|
|
|
|
Jackson
Lederer
,
Martin
Centurion
,
Lauren
Bertram
,
Lisa
Huang
,
Surjendu
Bhattacharyya
,
Sebastien
Boutet
,
Xinxin
Cheng
,
Stuart W.
Crane
,
Robert J.
England
,
Martin
Graßl
,
Lauren
Heald
,
Fuhao
Ji
,
Patrick
Kramer
,
Huynh
Van Sa Lam
,
Kirk
Larsen
,
Cuong
Le
,
Ming-Fu
Li
,
Yusong
Liu
,
Kenneth
Lopata
,
Mike
Minitti
,
Sri
Bhavya Muvva
,
J. Pedro F.
Nunes
,
Zane
Phelps
,
Sharon
Santhamma Philip
,
Krishna
Khakurel
,
Alexander
Hume Reid
,
Daniel
Rolles
,
Artem
Rudenko
,
Sajib
Kumar Saha
,
John
Searles
,
Xiaozhe
Shen
,
Jiayue
Wang
,
Stephen P.
Weathersby
,
Peter M.
Weber
,
Thomas J. A.
Wolf
,
Yanwei
Xiong
,
Tianzhe
Xu
,
Longteng
Yun
,
Haoran
Zhao
,
Adam
Kirrander
,
Jie
Yang
Abstract: Conjugated cyclic organic molecules are common across many fields such as pharmaceuticals, are naturally occurring in biological systems, and are used in synthetic materials. One particular area of interest from a photochemical point of view is the formation of highly strained cyclic organics. We investigate the photoinduced reaction of cyclopentadiene, a five-membered organic ring molecule, which can form strained three and four carbon rings after photoexcitation with UV light, with the gas-phase ultrafast electron diffraction instrument at the SLAC MeV-UED facility. Electron diffraction offers a direct probe sensitive to the nuclear geometry during the reaction, allowing for the determination of the distribution of products formed following photoexcitation. We observe the simultaneous formation of the highly strained ring-closed bicyclo[2.1.0]pentene and vibrationally hot cyclopentadiene within the temporal resolution of the experiment and determine the relative yield of all reaction products. The experimental results are in good agreement with the predictions of trajectory simulations.
|
Nov 2025
|
|
B18-Core EXAFS
|
Qingqing
Mei
,
Wenyuan
Huang
,
Longfei
Lin
,
Xue
Han
,
Shaojun
Xu
,
Bing
An
,
Svemir
Rudic
,
Rongsheng
Cai
,
Sarah J.
Haigh
,
Buxing
Han
,
Martin
Schroeder
,
Sihai
Yang
Diamond Proposal Number(s):
[36450]
Open Access
Abstract: The synthesis of organic amines via reductive amination of biomass-derived carbonyl compounds is an important target for sustainable chemical industries. The control of selectivity for the formation of primary amines versus secondary amines is challenging, and high temperature and pressures using H2 are required to generate the desired selectivity. Herein, we report the highly selective reductive amination of a broad range of aldehydes and ketones by NH3 and H2 over Rh/MFM-300(Cr) to form primary amines with a selectivity of up to 99% under ambient conditions. Inelastic neutron scattering reveals that the Rh species not only promote the hydrogenation process, but also catalyzes the ammonolysis of the Schiff base intermediate, facilitating the selective synthesis of primary amines. This protocol achieves selective reductive amination at 25 °C and 1 atm, providing an energy-efficient route to a broad spectrum of amines.
|
Nov 2025
|
|
I11-High Resolution Powder Diffraction
|
Diamond Proposal Number(s):
[34800]
Open Access
Abstract: Layered crystal structures are commonly found across organic and inorganic material systems. When in-plane atomic arrangement remains (nearly) identical, a stacking variation of these layers may result in twinning, planar disorder, or polytypes, a form of polymorphism derived from altering stacking sequences. In this work, we use multi-dimensional electron diffraction (ED) modalities to explore the microstructure of xanthine, an archetypal purine base with a layered crystal structure. Firstly, we identify and characterise the twin operator relating domains of Form I xanthine. We then solve the structure of a new xanthine polymorph, revealing that it is a polytype of Form I. Finally, interfaces between twin and polytype domains are visualised, whilst streaking in the diffraction patterns reveals the presence of planar disorder. Given these observations in the xanthine system, this work suggests that disorder on the nanoscale may be a commonly occurring phenomenon in layered organic molecular crystals.
|
Nov 2025
|
|
I03-Macromolecular Crystallography
I04-Macromolecular Crystallography
|
Bernard
Barlaam
,
Luz
Alonso-Crisostomo
,
Niall A.
Anderson
,
Argyrides
Argyrou
,
Peter C.
Astles
,
Elaine B.
Cadogan
,
Luca
Carlino
,
Gavin W.
Collie
,
Nichola L.
Davies
,
James
Hall
,
Linda
Kitching
,
Xianxi
Li
,
Filippos
Michopoulos
,
Alexander G.
Milbradt
,
Jenni
Nikkilä
,
Sarah
Northall
,
Mark J.
O'Connor
,
Xiaohiu
Pei
,
Joseph
Shaw
,
Danial
Slade
,
Harriet
Southgate
,
Darren
Stead
,
Christopher J.
Stubbs
,
Benjamin C.
Whitehurst
,
Bin
Xing
,
Yihao
Yuan
,
Jie
Zhou
Abstract: DNPH1 is a nucleotide pool sanitizer that cleaves 5-hydroxymethyl-2-deoxyuridine-5-monophosphate (hmdUMP), preventing incorporation of the correspondent non-natural nucleotide into DNA. Recent findings have demonstrated that loss of DNPH1 could potentiate the sensitivity of PARP inhibitors in homologous recombination repair (HRR)-deficient cancers. We report the optimization of a non-nucleoside-based series of DNPH1 inhibitors. Starting from a weak compound 1 (binding affinity pIC50 4.7), we identified compound 38 as a very potent inhibitor of DNPH1 (pIC50 9.3) using DNPH1 X-ray structure-guided drug design. Compound 38 demonstrated target engagement of DNPH1 in the SUM149PT cell line (pIC50 7.2). Using this tool compound, we then report the in vitro pharmacology of a DNPH1 inhibitor in the BRCA1 mutant SUM149PT cell line.
|
Nov 2025
|
|
I04-Macromolecular Crystallography
|
Zhe
Nie
,
Michael
Trzoss
,
Andrew T.
Placzek
,
Lynnie
Trzoss
,
Goran
Krilov
,
Shulu
Feng
,
Morgan
Lawrenz
,
Min
Ye
,
Netonia
Marshall
,
Karen H.
Dingley
,
Robert D.
Pelletier
,
W. George
Lai
,
Jeffrey A.
Bell
,
Haifeng
Tang
,
Paul
Devine
,
Zhijie
Liu
,
Peter
Skrdla
,
Roman
Shimanovich
,
Matt
Liu
,
Renchao
Wang
,
Xiaoming
Xu
,
Robert
Abel
,
Karen
Akinsanya
,
Wu
Yin
Abstract: MALT1 is a key component of the CARD11-BCL10-MALT1 (CBM) complex downstream from BTK on the B-cell receptor signaling pathway. It is a key mediator of NF-κB signaling and considered a potential therapeutic target for several subtypes of non-Hodgkin’s B-cell lymphomas. By applying advanced physics-based modeling techniques, including combining free energy calculations with machine learning methods and a chemistry-aware compound enumeration workflow, extensive sets of de novo design ideas were explored to quickly identify a novel hit series. Multiparameter optimization allowed efficient prioritization of molecules with good potency and drug-like properties during lead optimization, which led to the discovery of a highly potent MALT1 inhibitor, SGR-1505, with a well-balanced property profile. It demonstrated strong antitumor activity alone and in combination with BTK inhibitor in multiple in vivo B-cell lymphoma xenograft models and progressed to a phase 1 clinical trial in patients with mature B-cell neoplasms.
|
Oct 2025
|
|